Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Peficitinib can turn human fibroblasts into cells that help grow hair.

SKH1 hairless mice have identifiable epidermal stem cells with specific markers.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Vorasidenib can cause unusual hair growth.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Sgk3 is essential for normal hair follicle growth and maintenance.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

A woman's hair turned white after taking a cancer drug called dasatinib.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Dock5 is important for skin healing and could help treat diabetic wounds.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Inhibiting ODC can prevent UV-induced skin cancer.